开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2193053, encodeId=c1192193053c9, content=请问一下。投稿三天后状态变成了Awaiting Second Opinion Awaiting AE Assignment 是什么意思呀，有知道的大佬吗？？？拜谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bdc65472221, createdName=ms3000001648120624, createdTime=Wed Mar 13 21:42:53 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2200651, encodeId=f916220065108, content=投稿命中率:25.0 经验分享：两天了还在submitted to journal哭哭一定要平安啊我的崽啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8628244632, createdName=ms1000001525252032, createdTime=Sat Apr 27 01:47:59 CST 2024, time=2024-04-27, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2198095, encodeId=2979219809508, content=偏重的研究方向：临床医学;Tumor 经验分享：我今天也投稿了这个杂志，期待！！与大家一起交流学习，这个杂志影响因子是5分的不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40612215025, createdName=120e3267m32暂无昵称, createdTime=Fri Apr 12 08:08:47 CST 2024, time=2024-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180288, encodeId=285c2180288d9, content=research checklist，大家提交了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Jan 09 17:33:28 CST 2024, time=2024-01-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178642, encodeId=f00221e864287, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：消化;内镜 经验分享：2023年9月投稿，一直在等待分配审稿人，11月收到邮件要求作者推荐审稿人，回复邮件后1个月状态变成了Awaiting reviewer，过了1-2周后状态变成Awaiting AE recommendation，又过了几天变成Awaiting EIC decision，等了1天，2024-01-01直接接收，审稿人提了几个意见，但没要求修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4572634636, createdName=154528445, createdTime=Mon Jan 01 20:07:01 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=495600, encodeId=fa88495600ad, content=排号一万多，Awaiting Reviewer Selection两个月，写了询问信，结果一天后reject!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 15:27:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2173386, encodeId=451621e3386c0, content=这个怎么推荐审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d475418479, createdName=ms5000000090147273, createdTime=Wed Dec 06 22:38:42 CST 2023, time=2023-12-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152550, encodeId=d55a2152550b0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Sun Aug 13 12:00:10 CST 2023, time=2023-08-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2164398, encodeId=7ab1216439841, content=投稿命中率:5.0 经验分享：还沒送審, 沒原因就拒了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Mon Oct 23 15:42:45 CST 2023, time=2023-10-23, status=1, ipAttribution=澳门), GetPortalCommentsPageByObjectIdResponse(id=2162635, encodeId=7e1a216263516, content=投稿命中率:75.0 偏重的研究方向：影像;临床医学 经验分享：我觉得总体来说很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f9f5496228, createdName=ms4000000755205675, createdTime=Fri Oct 13 20:07:53 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省)]

2024-03-13 ms3000001648120624 来自上海

请问一下。投稿三天后状态变成了Awaiting Second Opinion Awaiting AE Assignment 是什么意思呀，有知道的大佬吗？？？拜谢！

151 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193053, encodeId=c1192193053c9, content=请问一下。投稿三天后状态变成了Awaiting Second Opinion Awaiting AE Assignment 是什么意思呀，有知道的大佬吗？？？拜谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bdc65472221, createdName=ms3000001648120624, createdTime=Wed Mar 13 21:42:53 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2200651, encodeId=f916220065108, content=投稿命中率:25.0 经验分享：两天了还在submitted to journal哭哭一定要平安啊我的崽啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8628244632, createdName=ms1000001525252032, createdTime=Sat Apr 27 01:47:59 CST 2024, time=2024-04-27, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2198095, encodeId=2979219809508, content=偏重的研究方向：临床医学;Tumor 经验分享：我今天也投稿了这个杂志，期待！！与大家一起交流学习，这个杂志影响因子是5分的不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40612215025, createdName=120e3267m32暂无昵称, createdTime=Fri Apr 12 08:08:47 CST 2024, time=2024-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180288, encodeId=285c2180288d9, content=research checklist，大家提交了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Jan 09 17:33:28 CST 2024, time=2024-01-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178642, encodeId=f00221e864287, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：消化;内镜 经验分享：2023年9月投稿，一直在等待分配审稿人，11月收到邮件要求作者推荐审稿人，回复邮件后1个月状态变成了Awaiting reviewer，过了1-2周后状态变成Awaiting AE recommendation，又过了几天变成Awaiting EIC decision，等了1天，2024-01-01直接接收，审稿人提了几个意见，但没要求修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4572634636, createdName=154528445, createdTime=Mon Jan 01 20:07:01 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=495600, encodeId=fa88495600ad, content=排号一万多，Awaiting Reviewer Selection两个月，写了询问信，结果一天后reject!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 15:27:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2173386, encodeId=451621e3386c0, content=这个怎么推荐审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d475418479, createdName=ms5000000090147273, createdTime=Wed Dec 06 22:38:42 CST 2023, time=2023-12-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152550, encodeId=d55a2152550b0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Sun Aug 13 12:00:10 CST 2023, time=2023-08-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2164398, encodeId=7ab1216439841, content=投稿命中率:5.0 经验分享：还沒送審, 沒原因就拒了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Mon Oct 23 15:42:45 CST 2023, time=2023-10-23, status=1, ipAttribution=澳门), GetPortalCommentsPageByObjectIdResponse(id=2162635, encodeId=7e1a216263516, content=投稿命中率:75.0 偏重的研究方向：影像;临床医学 经验分享：我觉得总体来说很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f9f5496228, createdName=ms4000000755205675, createdTime=Fri Oct 13 20:07:53 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省)]

2024-04-27 ms1000001525252032 来自伊利诺伊

投稿命中率:25.0
经验分享：两天了还在submitted to journal哭哭一定要平安啊我的崽啊

63 0

[GetPortalCommentsPageByObjectIdResponse(id=2193053, encodeId=c1192193053c9, content=请问一下。投稿三天后状态变成了Awaiting Second Opinion Awaiting AE Assignment 是什么意思呀，有知道的大佬吗？？？拜谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bdc65472221, createdName=ms3000001648120624, createdTime=Wed Mar 13 21:42:53 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2200651, encodeId=f916220065108, content=投稿命中率:25.0 经验分享：两天了还在submitted to journal哭哭一定要平安啊我的崽啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8628244632, createdName=ms1000001525252032, createdTime=Sat Apr 27 01:47:59 CST 2024, time=2024-04-27, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2198095, encodeId=2979219809508, content=偏重的研究方向：临床医学;Tumor 经验分享：我今天也投稿了这个杂志，期待！！与大家一起交流学习，这个杂志影响因子是5分的不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40612215025, createdName=120e3267m32暂无昵称, createdTime=Fri Apr 12 08:08:47 CST 2024, time=2024-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180288, encodeId=285c2180288d9, content=research checklist，大家提交了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Jan 09 17:33:28 CST 2024, time=2024-01-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178642, encodeId=f00221e864287, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：消化;内镜 经验分享：2023年9月投稿，一直在等待分配审稿人，11月收到邮件要求作者推荐审稿人，回复邮件后1个月状态变成了Awaiting reviewer，过了1-2周后状态变成Awaiting AE recommendation，又过了几天变成Awaiting EIC decision，等了1天，2024-01-01直接接收，审稿人提了几个意见，但没要求修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4572634636, createdName=154528445, createdTime=Mon Jan 01 20:07:01 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=495600, encodeId=fa88495600ad, content=排号一万多，Awaiting Reviewer Selection两个月，写了询问信，结果一天后reject!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 15:27:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2173386, encodeId=451621e3386c0, content=这个怎么推荐审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d475418479, createdName=ms5000000090147273, createdTime=Wed Dec 06 22:38:42 CST 2023, time=2023-12-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152550, encodeId=d55a2152550b0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Sun Aug 13 12:00:10 CST 2023, time=2023-08-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2164398, encodeId=7ab1216439841, content=投稿命中率:5.0 经验分享：还沒送審, 沒原因就拒了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Mon Oct 23 15:42:45 CST 2023, time=2023-10-23, status=1, ipAttribution=澳门), GetPortalCommentsPageByObjectIdResponse(id=2162635, encodeId=7e1a216263516, content=投稿命中率:75.0 偏重的研究方向：影像;临床医学 经验分享：我觉得总体来说很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f9f5496228, createdName=ms4000000755205675, createdTime=Fri Oct 13 20:07:53 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省)]

2024-04-12 120e3267m32暂无昵称

偏重的研究方向：临床医学;Tumor
经验分享：我今天也投稿了这个杂志，期待！！与大家一起交流学习，这个杂志影响因子是5分的不？

1 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193053, encodeId=c1192193053c9, content=请问一下。投稿三天后状态变成了Awaiting Second Opinion Awaiting AE Assignment 是什么意思呀，有知道的大佬吗？？？拜谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bdc65472221, createdName=ms3000001648120624, createdTime=Wed Mar 13 21:42:53 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2200651, encodeId=f916220065108, content=投稿命中率:25.0 经验分享：两天了还在submitted to journal哭哭一定要平安啊我的崽啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8628244632, createdName=ms1000001525252032, createdTime=Sat Apr 27 01:47:59 CST 2024, time=2024-04-27, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2198095, encodeId=2979219809508, content=偏重的研究方向：临床医学;Tumor 经验分享：我今天也投稿了这个杂志，期待！！与大家一起交流学习，这个杂志影响因子是5分的不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40612215025, createdName=120e3267m32暂无昵称, createdTime=Fri Apr 12 08:08:47 CST 2024, time=2024-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180288, encodeId=285c2180288d9, content=research checklist，大家提交了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Jan 09 17:33:28 CST 2024, time=2024-01-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178642, encodeId=f00221e864287, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：消化;内镜 经验分享：2023年9月投稿，一直在等待分配审稿人，11月收到邮件要求作者推荐审稿人，回复邮件后1个月状态变成了Awaiting reviewer，过了1-2周后状态变成Awaiting AE recommendation，又过了几天变成Awaiting EIC decision，等了1天，2024-01-01直接接收，审稿人提了几个意见，但没要求修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4572634636, createdName=154528445, createdTime=Mon Jan 01 20:07:01 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=495600, encodeId=fa88495600ad, content=排号一万多，Awaiting Reviewer Selection两个月，写了询问信，结果一天后reject!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 15:27:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2173386, encodeId=451621e3386c0, content=这个怎么推荐审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d475418479, createdName=ms5000000090147273, createdTime=Wed Dec 06 22:38:42 CST 2023, time=2023-12-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152550, encodeId=d55a2152550b0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Sun Aug 13 12:00:10 CST 2023, time=2023-08-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2164398, encodeId=7ab1216439841, content=投稿命中率:5.0 经验分享：还沒送審, 沒原因就拒了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Mon Oct 23 15:42:45 CST 2023, time=2023-10-23, status=1, ipAttribution=澳门), GetPortalCommentsPageByObjectIdResponse(id=2162635, encodeId=7e1a216263516, content=投稿命中率:75.0 偏重的研究方向：影像;临床医学 经验分享：我觉得总体来说很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f9f5496228, createdName=ms4000000755205675, createdTime=Fri Oct 13 20:07:53 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省)]

2024-01-09 国统乃我辈之愿来自广东省

research checklist，大家提交了吗

159 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193053, encodeId=c1192193053c9, content=请问一下。投稿三天后状态变成了Awaiting Second Opinion Awaiting AE Assignment 是什么意思呀，有知道的大佬吗？？？拜谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bdc65472221, createdName=ms3000001648120624, createdTime=Wed Mar 13 21:42:53 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2200651, encodeId=f916220065108, content=投稿命中率:25.0 经验分享：两天了还在submitted to journal哭哭一定要平安啊我的崽啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8628244632, createdName=ms1000001525252032, createdTime=Sat Apr 27 01:47:59 CST 2024, time=2024-04-27, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2198095, encodeId=2979219809508, content=偏重的研究方向：临床医学;Tumor 经验分享：我今天也投稿了这个杂志，期待！！与大家一起交流学习，这个杂志影响因子是5分的不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40612215025, createdName=120e3267m32暂无昵称, createdTime=Fri Apr 12 08:08:47 CST 2024, time=2024-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180288, encodeId=285c2180288d9, content=research checklist，大家提交了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Jan 09 17:33:28 CST 2024, time=2024-01-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178642, encodeId=f00221e864287, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：消化;内镜 经验分享：2023年9月投稿，一直在等待分配审稿人，11月收到邮件要求作者推荐审稿人，回复邮件后1个月状态变成了Awaiting reviewer，过了1-2周后状态变成Awaiting AE recommendation，又过了几天变成Awaiting EIC decision，等了1天，2024-01-01直接接收，审稿人提了几个意见，但没要求修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4572634636, createdName=154528445, createdTime=Mon Jan 01 20:07:01 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=495600, encodeId=fa88495600ad, content=排号一万多，Awaiting Reviewer Selection两个月，写了询问信，结果一天后reject!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 15:27:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2173386, encodeId=451621e3386c0, content=这个怎么推荐审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d475418479, createdName=ms5000000090147273, createdTime=Wed Dec 06 22:38:42 CST 2023, time=2023-12-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152550, encodeId=d55a2152550b0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Sun Aug 13 12:00:10 CST 2023, time=2023-08-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2164398, encodeId=7ab1216439841, content=投稿命中率:5.0 经验分享：还沒送審, 沒原因就拒了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Mon Oct 23 15:42:45 CST 2023, time=2023-10-23, status=1, ipAttribution=澳门), GetPortalCommentsPageByObjectIdResponse(id=2162635, encodeId=7e1a216263516, content=投稿命中率:75.0 偏重的研究方向：影像;临床医学 经验分享：我觉得总体来说很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f9f5496228, createdName=ms4000000755205675, createdTime=Fri Oct 13 20:07:53 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省)]

2024-01-01 154528445 来自广东省

审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向：消化;内镜
经验分享：2023年9月投稿，一直在等待分配审稿人，11月收到邮件要求作者推荐审稿人，回复邮件后1个月状态变成了Awaiting reviewer，过了1-2周后状态变成Awaiting AE recommendation，又过了几天变成Awaiting EIC decision，等了1天，2024-01-01直接接收，审稿人提了几个意见，但没要求修改

154 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193053, encodeId=c1192193053c9, content=请问一下。投稿三天后状态变成了Awaiting Second Opinion Awaiting AE Assignment 是什么意思呀，有知道的大佬吗？？？拜谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bdc65472221, createdName=ms3000001648120624, createdTime=Wed Mar 13 21:42:53 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2200651, encodeId=f916220065108, content=投稿命中率:25.0 经验分享：两天了还在submitted to journal哭哭一定要平安啊我的崽啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8628244632, createdName=ms1000001525252032, createdTime=Sat Apr 27 01:47:59 CST 2024, time=2024-04-27, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2198095, encodeId=2979219809508, content=偏重的研究方向：临床医学;Tumor 经验分享：我今天也投稿了这个杂志，期待！！与大家一起交流学习，这个杂志影响因子是5分的不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40612215025, createdName=120e3267m32暂无昵称, createdTime=Fri Apr 12 08:08:47 CST 2024, time=2024-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180288, encodeId=285c2180288d9, content=research checklist，大家提交了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Jan 09 17:33:28 CST 2024, time=2024-01-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178642, encodeId=f00221e864287, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：消化;内镜 经验分享：2023年9月投稿，一直在等待分配审稿人，11月收到邮件要求作者推荐审稿人，回复邮件后1个月状态变成了Awaiting reviewer，过了1-2周后状态变成Awaiting AE recommendation，又过了几天变成Awaiting EIC decision，等了1天，2024-01-01直接接收，审稿人提了几个意见，但没要求修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4572634636, createdName=154528445, createdTime=Mon Jan 01 20:07:01 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=495600, encodeId=fa88495600ad, content=排号一万多，Awaiting Reviewer Selection两个月，写了询问信，结果一天后reject!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 15:27:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2173386, encodeId=451621e3386c0, content=这个怎么推荐审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d475418479, createdName=ms5000000090147273, createdTime=Wed Dec 06 22:38:42 CST 2023, time=2023-12-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152550, encodeId=d55a2152550b0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Sun Aug 13 12:00:10 CST 2023, time=2023-08-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2164398, encodeId=7ab1216439841, content=投稿命中率:5.0 经验分享：还沒送審, 沒原因就拒了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Mon Oct 23 15:42:45 CST 2023, time=2023-10-23, status=1, ipAttribution=澳门), GetPortalCommentsPageByObjectIdResponse(id=2162635, encodeId=7e1a216263516, content=投稿命中率:75.0 偏重的研究方向：影像;临床医学 经验分享：我觉得总体来说很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f9f5496228, createdName=ms4000000755205675, createdTime=Fri Oct 13 20:07:53 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省)]

2013-05-08 匿名用户

排号一万多，Awaiting Reviewer Selection两个月，写了询问信，结果一天后reject!

578 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193053, encodeId=c1192193053c9, content=请问一下。投稿三天后状态变成了Awaiting Second Opinion Awaiting AE Assignment 是什么意思呀，有知道的大佬吗？？？拜谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bdc65472221, createdName=ms3000001648120624, createdTime=Wed Mar 13 21:42:53 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2200651, encodeId=f916220065108, content=投稿命中率:25.0 经验分享：两天了还在submitted to journal哭哭一定要平安啊我的崽啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8628244632, createdName=ms1000001525252032, createdTime=Sat Apr 27 01:47:59 CST 2024, time=2024-04-27, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2198095, encodeId=2979219809508, content=偏重的研究方向：临床医学;Tumor 经验分享：我今天也投稿了这个杂志，期待！！与大家一起交流学习，这个杂志影响因子是5分的不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40612215025, createdName=120e3267m32暂无昵称, createdTime=Fri Apr 12 08:08:47 CST 2024, time=2024-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180288, encodeId=285c2180288d9, content=research checklist，大家提交了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Jan 09 17:33:28 CST 2024, time=2024-01-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178642, encodeId=f00221e864287, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：消化;内镜 经验分享：2023年9月投稿，一直在等待分配审稿人，11月收到邮件要求作者推荐审稿人，回复邮件后1个月状态变成了Awaiting reviewer，过了1-2周后状态变成Awaiting AE recommendation，又过了几天变成Awaiting EIC decision，等了1天，2024-01-01直接接收，审稿人提了几个意见，但没要求修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4572634636, createdName=154528445, createdTime=Mon Jan 01 20:07:01 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=495600, encodeId=fa88495600ad, content=排号一万多，Awaiting Reviewer Selection两个月，写了询问信，结果一天后reject!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 15:27:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2173386, encodeId=451621e3386c0, content=这个怎么推荐审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d475418479, createdName=ms5000000090147273, createdTime=Wed Dec 06 22:38:42 CST 2023, time=2023-12-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152550, encodeId=d55a2152550b0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Sun Aug 13 12:00:10 CST 2023, time=2023-08-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2164398, encodeId=7ab1216439841, content=投稿命中率:5.0 经验分享：还沒送審, 沒原因就拒了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Mon Oct 23 15:42:45 CST 2023, time=2023-10-23, status=1, ipAttribution=澳门), GetPortalCommentsPageByObjectIdResponse(id=2162635, encodeId=7e1a216263516, content=投稿命中率:75.0 偏重的研究方向：影像;临床医学 经验分享：我觉得总体来说很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f9f5496228, createdName=ms4000000755205675, createdTime=Fri Oct 13 20:07:53 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省)]

2023-12-06 ms5000000090147273 来自北京

这个怎么推荐审稿人啊

166 0

[GetPortalCommentsPageByObjectIdResponse(id=2193053, encodeId=c1192193053c9, content=请问一下。投稿三天后状态变成了Awaiting Second Opinion Awaiting AE Assignment 是什么意思呀，有知道的大佬吗？？？拜谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bdc65472221, createdName=ms3000001648120624, createdTime=Wed Mar 13 21:42:53 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2200651, encodeId=f916220065108, content=投稿命中率:25.0 经验分享：两天了还在submitted to journal哭哭一定要平安啊我的崽啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8628244632, createdName=ms1000001525252032, createdTime=Sat Apr 27 01:47:59 CST 2024, time=2024-04-27, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2198095, encodeId=2979219809508, content=偏重的研究方向：临床医学;Tumor 经验分享：我今天也投稿了这个杂志，期待！！与大家一起交流学习，这个杂志影响因子是5分的不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40612215025, createdName=120e3267m32暂无昵称, createdTime=Fri Apr 12 08:08:47 CST 2024, time=2024-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180288, encodeId=285c2180288d9, content=research checklist，大家提交了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Jan 09 17:33:28 CST 2024, time=2024-01-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178642, encodeId=f00221e864287, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：消化;内镜 经验分享：2023年9月投稿，一直在等待分配审稿人，11月收到邮件要求作者推荐审稿人，回复邮件后1个月状态变成了Awaiting reviewer，过了1-2周后状态变成Awaiting AE recommendation，又过了几天变成Awaiting EIC decision，等了1天，2024-01-01直接接收，审稿人提了几个意见，但没要求修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4572634636, createdName=154528445, createdTime=Mon Jan 01 20:07:01 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=495600, encodeId=fa88495600ad, content=排号一万多，Awaiting Reviewer Selection两个月，写了询问信，结果一天后reject!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 15:27:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2173386, encodeId=451621e3386c0, content=这个怎么推荐审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d475418479, createdName=ms5000000090147273, createdTime=Wed Dec 06 22:38:42 CST 2023, time=2023-12-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152550, encodeId=d55a2152550b0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Sun Aug 13 12:00:10 CST 2023, time=2023-08-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2164398, encodeId=7ab1216439841, content=投稿命中率:5.0 经验分享：还沒送審, 沒原因就拒了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Mon Oct 23 15:42:45 CST 2023, time=2023-10-23, status=1, ipAttribution=澳门), GetPortalCommentsPageByObjectIdResponse(id=2162635, encodeId=7e1a216263516, content=投稿命中率:75.0 偏重的研究方向：影像;临床医学 经验分享：我觉得总体来说很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f9f5496228, createdName=ms4000000755205675, createdTime=Fri Oct 13 20:07:53 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省)]

2023-08-13 ms5000001091496643 来自浙江省

审稿速度:1.0 | 投稿命中率:95.0
经验分享：还没投

163 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193053, encodeId=c1192193053c9, content=请问一下。投稿三天后状态变成了Awaiting Second Opinion Awaiting AE Assignment 是什么意思呀，有知道的大佬吗？？？拜谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bdc65472221, createdName=ms3000001648120624, createdTime=Wed Mar 13 21:42:53 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2200651, encodeId=f916220065108, content=投稿命中率:25.0 经验分享：两天了还在submitted to journal哭哭一定要平安啊我的崽啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8628244632, createdName=ms1000001525252032, createdTime=Sat Apr 27 01:47:59 CST 2024, time=2024-04-27, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2198095, encodeId=2979219809508, content=偏重的研究方向：临床医学;Tumor 经验分享：我今天也投稿了这个杂志，期待！！与大家一起交流学习，这个杂志影响因子是5分的不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40612215025, createdName=120e3267m32暂无昵称, createdTime=Fri Apr 12 08:08:47 CST 2024, time=2024-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180288, encodeId=285c2180288d9, content=research checklist，大家提交了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Jan 09 17:33:28 CST 2024, time=2024-01-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178642, encodeId=f00221e864287, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：消化;内镜 经验分享：2023年9月投稿，一直在等待分配审稿人，11月收到邮件要求作者推荐审稿人，回复邮件后1个月状态变成了Awaiting reviewer，过了1-2周后状态变成Awaiting AE recommendation，又过了几天变成Awaiting EIC decision，等了1天，2024-01-01直接接收，审稿人提了几个意见，但没要求修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4572634636, createdName=154528445, createdTime=Mon Jan 01 20:07:01 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=495600, encodeId=fa88495600ad, content=排号一万多，Awaiting Reviewer Selection两个月，写了询问信，结果一天后reject!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 15:27:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2173386, encodeId=451621e3386c0, content=这个怎么推荐审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d475418479, createdName=ms5000000090147273, createdTime=Wed Dec 06 22:38:42 CST 2023, time=2023-12-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152550, encodeId=d55a2152550b0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Sun Aug 13 12:00:10 CST 2023, time=2023-08-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2164398, encodeId=7ab1216439841, content=投稿命中率:5.0 经验分享：还沒送審, 沒原因就拒了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Mon Oct 23 15:42:45 CST 2023, time=2023-10-23, status=1, ipAttribution=澳门), GetPortalCommentsPageByObjectIdResponse(id=2162635, encodeId=7e1a216263516, content=投稿命中率:75.0 偏重的研究方向：影像;临床医学 经验分享：我觉得总体来说很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f9f5496228, createdName=ms4000000755205675, createdTime=Fri Oct 13 20:07:53 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省)]

2023-10-23 ms8000001562779487 来自澳门

投稿命中率:5.0
经验分享：还沒送審, 沒原因就拒了~

155 0

[GetPortalCommentsPageByObjectIdResponse(id=2193053, encodeId=c1192193053c9, content=请问一下。投稿三天后状态变成了Awaiting Second Opinion Awaiting AE Assignment 是什么意思呀，有知道的大佬吗？？？拜谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bdc65472221, createdName=ms3000001648120624, createdTime=Wed Mar 13 21:42:53 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2200651, encodeId=f916220065108, content=投稿命中率:25.0 经验分享：两天了还在submitted to journal哭哭一定要平安啊我的崽啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8628244632, createdName=ms1000001525252032, createdTime=Sat Apr 27 01:47:59 CST 2024, time=2024-04-27, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2198095, encodeId=2979219809508, content=偏重的研究方向：临床医学;Tumor 经验分享：我今天也投稿了这个杂志，期待！！与大家一起交流学习，这个杂志影响因子是5分的不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40612215025, createdName=120e3267m32暂无昵称, createdTime=Fri Apr 12 08:08:47 CST 2024, time=2024-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180288, encodeId=285c2180288d9, content=research checklist，大家提交了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Jan 09 17:33:28 CST 2024, time=2024-01-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178642, encodeId=f00221e864287, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：消化;内镜 经验分享：2023年9月投稿，一直在等待分配审稿人，11月收到邮件要求作者推荐审稿人，回复邮件后1个月状态变成了Awaiting reviewer，过了1-2周后状态变成Awaiting AE recommendation，又过了几天变成Awaiting EIC decision，等了1天，2024-01-01直接接收，审稿人提了几个意见，但没要求修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4572634636, createdName=154528445, createdTime=Mon Jan 01 20:07:01 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=495600, encodeId=fa88495600ad, content=排号一万多，Awaiting Reviewer Selection两个月，写了询问信，结果一天后reject!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 15:27:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2173386, encodeId=451621e3386c0, content=这个怎么推荐审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d475418479, createdName=ms5000000090147273, createdTime=Wed Dec 06 22:38:42 CST 2023, time=2023-12-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152550, encodeId=d55a2152550b0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Sun Aug 13 12:00:10 CST 2023, time=2023-08-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2164398, encodeId=7ab1216439841, content=投稿命中率:5.0 经验分享：还沒送審, 沒原因就拒了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Mon Oct 23 15:42:45 CST 2023, time=2023-10-23, status=1, ipAttribution=澳门), GetPortalCommentsPageByObjectIdResponse(id=2162635, encodeId=7e1a216263516, content=投稿命中率:75.0 偏重的研究方向：影像;临床医学 经验分享：我觉得总体来说很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f9f5496228, createdName=ms4000000755205675, createdTime=Fri Oct 13 20:07:53 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省)]

2023-10-13 ms4000000755205675 来自浙江省

投稿命中率:75.0
偏重的研究方向：影像;临床医学
经验分享：我觉得总体来说很友好的杂志

159 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务